Literature DB >> 17182595

A local antigen-driven humoral response is present in the inflammatory myopathies.

Elizabeth M Bradshaw1, Ana Orihuela, Shannon L McArdel, Mohammad Salajegheh, Anthony A Amato, David A Hafler, Steven A Greenberg, Kevin C O'Connor.   

Abstract

The inflammatory myopathies are putative autoimmune disorders characterized by muscle weakness and the presence of intramuscular inflammatory infiltrates. Although inclusion body myositis and polymyositis have been characterized as cytotoxic CD8(+) T cell-mediated diseases, we recently demonstrated high frequencies of CD138(+) plasma cells in the inflamed muscle tissue of patients with these diseases. To gain a deeper understanding of the role these B cell family members play in the disease pathology, we examined the molecular characteristics of the H chain portion of the Ag receptor. Biopsies of muscle tissue were sectioned and tissue regions and individual cells were isolated through laser capture microdissection. Ig H chain gene transcripts isolated from the sections, regions, and cells were used to determine the variable region gene sequences. Analysis of these sequences revealed clear evidence of affinity maturation in that significant somatic mutation, isotype switching, receptor revision, codon insertion/deletion, and oligoclonal expansion had occurred within the B and plasma cell populations. Moreover, analysis of tissue regions isolated by laser capture microdissection revealed both clonal expansion and variation, suggesting that local B cell maturation occurs within muscle. In contrast, sequences from control muscle tissues and peripheral blood revealed none of these characteristics found in inflammatory myopathy muscle tissue. Collectively, these data demonstrate that Ag drives a B cell Ag-specific response in muscle in patients with dermatomyositis, inclusion body myositis, and polymyositis. These findings highlight the need for a revision of the current paradigm of exclusively T cell-mediated intramuscular Ag-specific autoimmunity in inclusion body myositis and polymyositis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17182595     DOI: 10.4049/jimmunol.178.1.547

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

Review 1.  Advances in the immunobiology and treatment of inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Curr Rheumatol Rep       Date:  2007-08       Impact factor: 4.592

2.  Distinct inflammatory properties of late-activated macrophages in inflammatory myopathies.

Authors:  K M Rostasy; J Schmidt; E Bahn; T Pfander; M Piepkorn; E Wilichowski; J Schulz-Schaeffer
Journal:  Acta Myol       Date:  2008-10

3.  Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis.

Authors:  Kenneth C Parker; Sek Won Kong; Ronan J Walsh; Mohammad Salajegheh; Behzad Moghadaszadeh; Anthony A Amato; Remedios Nazareno; Yin Yin Lin; Bryan Krastins; David A Sarracino; Alan H Beggs; Jack L Pinkus; Steven A Greenberg
Journal:  Muscle Nerve       Date:  2009-06       Impact factor: 3.217

4.  The inflammatory milieu in idiopathic inflammatory myositis.

Authors:  Ann M Reed; Floranne Ernste
Journal:  Curr Rheumatol Rep       Date:  2009-08       Impact factor: 4.592

Review 5.  Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.

Authors:  Frédérique Truffault; Vincent de Montpreville; Bruno Eymard; Tarek Sharshar; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 6.  Ectopic lymphoid neogenesis in rheumatic autoimmune diseases.

Authors:  Michele Bombardieri; Myles Lewis; Costantino Pitzalis
Journal:  Nat Rev Rheumatol       Date:  2017-02-09       Impact factor: 20.543

Review 7.  Inclusion Body Myositis: Update on Pathogenesis and Treatment.

Authors:  Elie Naddaf; Richard J Barohn; Mazen M Dimachkie
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

8.  Profiling human antibody responses by integrated single-cell analysis.

Authors:  Adebola O Ogunniyi; Brittany A Thomas; Timothy J Politano; Navin Varadarajan; Elise Landais; Pascal Poignard; Bruce D Walker; Douglas S Kwon; J Christopher Love
Journal:  Vaccine       Date:  2014-03-03       Impact factor: 3.641

9.  Seropositivity for NT5c1A antibody in sporadic inclusion body myositis predicts more severe motor, bulbar and respiratory involvement.

Authors:  N A Goyal; T M Cash; U Alam; S Enam; P Tierney; N Araujo; F H Mozaffar; A Pestronk; T Mozaffar
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-04-09       Impact factor: 10.154

Review 10.  Novel approaches for identifying target antigens of autoreactive human B and T cells.

Authors:  Klaus Dornmair; Edgar Meinl; Reinhard Hohlfeld
Journal:  Semin Immunopathol       Date:  2009-09-11       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.